All Stories

Following pharma's tariff trend, AbbVie unveils $10B US investment in 10 years

AbbVie aims to invest $10 billion in the U.S. through 2035 to support its current growth plans and expand into new areas like obesity, the company’s CEO, Rob Michael, said on a call Friday.

Apr 25, 2025 - 17:04
 0
Following pharma's tariff trend, AbbVie unveils $10B US investment in 10 years
AbbVie aims to invest $10 billion in the U.S. through 2035 to support its current growth plans and expand into new areas like obesity, the company’s CEO, Rob Michael, said on a call Friday.
Read More

Tags:

Previous Article

GAC debuted at the Auto Shanghai, unveiling the “X-SOUL AI Panorama” and four ne...

Next Article

Taste Radio: Scaling Your Tribe. The Komos Way.

Related Posts

Eisai, Biogen's Leqembi emerges from safety reappraisal unscathed as Europe's CHMP endorses slate of new drugs and label expansions

Eisai, Biogen's Leqembi emerges from safety reappraisal...

Feb 28, 2025  0

As Humira succession plan played out, AbbVie's Rob Michael collected $18.5M in his first year as CEO

As Humira succession plan played out, AbbVie's Rob Mich...

Mar 11, 2025  0

Eli Lilly logs massive Q4 revenue jump—but it's not just thanks to Mounjaro and Zepbound

Eli Lilly logs massive Q4 revenue jump—but it's not jus...

Feb 9, 2025  0